Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) General Information

Description

Portfolio of cardiovascular disease drug patents.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Planegg
  • Germany
Primary Industry
Buildings and Property
Corporate Office
  • Planegg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)‘s full profile, request access.

Request a free trial

Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)‘s full profile, request access.

Request a free trial

Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) FAQs

  • Where is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) headquartered?

    Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is headquartered in Planegg, Germany.

  • What industry is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) in?

    Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s primary industry is Buildings and Property.

  • Is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) a private or public company?

    Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is a Private company.

  • What is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s current revenue?

    The current revenue for Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is .

  • Who are Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s investors?

    Secarna Pharmaceuticals has invested in Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent).

  • When was Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) acquired?

    Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) was acquired on 23-Mar-2020.

  • Who acquired Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)?

    Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) was acquired by Lipigon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process